Former Chief Financial Officer · AVENUE THERAPEUTICS, INC. (ATXI)

Joseph Vazzano

A named executive officer of AVENUE THERAPEUTICS in every fiscal year CompBrief holds from FY2017 to FY2022. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2022

$21,335

Salary $20,514Stock awards $0

FY2021: $441,325

3rd of 3 named executive officers at Avenue Therapeutics by FY2022 total.

4 named officers on file for AVENUE THERAPEUTICS, FY2022

Joseph Vazzano’s pay file — $29

  • 6 fiscal years of pay, line by line
  • 3 equity grants, each cited to its filing

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how AVENUE THERAPEUTICS’s whole pay program stands against its peers

  • AVENUE THERAPEUTICS’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on ATXI→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 28, 2023 (DEF 14A).

Free

Get Joseph Vazzano’s full pay file as a PDF — free

More than this page: up to 10 years of Joseph’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Joseph Vazzano compensation by year

AVENUE THERAPEUTICS Summary Compensation Table · all 6 fiscal years held
In US dollars, as AVENUE THERAPEUTICS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2017FY2018FY2019FY2020FY2021FY2022
Salary$74,756$175,100$198,113$206,000$255,747$20,514
Bonus$48,630$0$0$0$80,513$0
Stock awards$203,100$103,800$0$0$93,465$0
Option awards$0$0$0$0$0$0
Non-equity incentive$0$67,851$50,000$0$0$0
Pension and deferred compensation$0$0$0$0$0$0
All other$1,138$7,777$10,666$8,890$11,600$822
Total$327,624$354,528$258,779$214,890$441,325$21,335

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: AVENUE THERAPEUTICS, INC. DEF 14A filed April 28, 2023, accession 0001104659-23-052920, and prior-year filings. Open the filing on EDGAR.

How this page was built: the AVENUE THERAPEUTICS, INC. filed document, accession 0001104659-23-052920. Every figure is read from that document and cited to the page and table it appears in. Filed April 28, 2023.

$328K
$355K
$259K
$215K
$441K
$21K
FY17
FY18
FY19
FY20
FY21
FY22
SalaryBonusNon-equity incentiveStock awardsAll other

Equity holdings

unvested awards at FY2021 year-end
TypeUnvested unitsValue at year-endExercise price
RSU100,505$91,460—
RSU7,500$6,825—

Per the Outstanding Equity Awards at Fiscal Year-End table in AVENUE THERAPEUTICS, INC.'s FY2021 proxy; value at the fiscal year-end close, as the company printed it.

AVENUE THERAPEUTICS’s named executive officers, FY2022

as the company reported each
Named executive officerRoleFY2022 total
Lucy LuFormer Chief Executive Officer$570,859
Alexandra MacLeanChief Executive Officer$280,542
Joseph Vazzano · this pageFormer Chief Financial Officer$21,335
David JinInterim Chief Financial Officer—

The full AVENUE THERAPEUTICS compensation record

free company brief

This page is one person within AVENUE THERAPEUTICS's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are AVENUE THERAPEUTICS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Joseph Vazzano's compensation dossier · One-time report. No refunds.